| Schedule of net Income (Loss) Per Share, Basic and Diluted |
The following table sets forth the computation of the Company’s basic and diluted net income (loss) per share: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | June 28,
2025 | | June 29,
2024 | | June 28,
2025 | | June 29,
2024 | | (In thousands, except share and per share data) | | | | | | | | | Numerator: | | | | | | | | Net income (loss) - basic and diluted | $ | (3,379) | | | $ | 3,709 | | | $ | (23,286) | | | $ | 14,947 | | | Denominator: | | | | | | | | | Weighted-average shares of common stock—basic | 120,423,439 | | 122,553,129 | | 120,804,730 | | | 123,828,150 | | | Effect of potentially dilutive stock options | — | | | 1,116,000 | | | — | | | 956,598 | | | Effect of RSUs | — | | | 3,543,526 | | | — | | | 3,085,571 | | | Effect of PSUs | — | | | 32,804 | | | — | | | 16,049 | | | Weighted-average shares of common stock—diluted | 120,423,439 | | 127,245,459 | | 120,804,730 | | | 127,886,368 | | | Net income (loss) per share: | | | | | | | | | Basic | $ | (0.03) | | | $ | 0.03 | | | $ | (0.19) | | | $ | 0.12 | | | Diluted | $ | (0.03) | | | $ | 0.03 | | | $ | (0.19) | | | $ | 0.12 | |
|
| Schedule of Antidilutive Securities |
The following shares were excluded from the computation of diluted net income (loss) per share because their effect would have been antidilutive: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | June 28,
2025 | | June 29,
2024 | | June 28,
2025 | | June 29,
2024 | | Stock options to purchase common stock | 6,338,165 | | 6,371,604 | | 6,673,403 | | 6,998,738 | | Restricted stock units | 10,863,006 | | 9,556,879 | | 13,394,270 | | 9,828,619 | | Performance stock units | 516,697 | | 187,255 | | 201,691 | | 88,030 | | Total | 17,717,868 | | 16,115,738 | | 20,269,364 | | 16,915,387 |
|